| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 3, 2025 | Oct 7, 2025 | Voyager Therapeutics, Inc. | CFO | Sell | 46.3 | -7,666 | -5.83% | ✗ | $36.6K |
| May 6, 2024 | May 7, 2024 | Vor Biopharma Inc. | CFO | Sell | 52.5 | -834 | -0.44% | ✗ | $1.5K |
| May 1, 2024 | May 3, 2024 | Vor Biopharma Inc. | CFO | Sell | 52.5 | -917 | -0.48% | ✗ | $1.6K |
| Mar 1, 2024 | Mar 5, 2024 | Vor Biopharma Inc. | CFO | Sell | 46.3 | -6,310 | -3.20% | ✗ | $14.3K |
| Feb 6, 2024 | Feb 8, 2024 | Vor Biopharma Inc. | CFO | Sell | 52.5 | -985 | -0.50% | ✗ | $2.3K |
| Nov 6, 2023 | Nov 8, 2023 | Vor Biopharma Inc. | CFO | Sell | 50.0 | -834 | -0.57% | ✗ | $1.5K |
| Sep 1, 2023 | Sep 6, 2023 | Vor Biopharma Inc. | CFO | Sell | 46.3 | -6,310 | -4.13% | ✗ | $16.8K |
| Aug 7, 2023 | Aug 9, 2023 | Vor Biopharma Inc. | CFO | Sell | 50.0 | -834 | -0.54% | ✗ | $2.2K |
| May 8, 2023 | May 10, 2023 | Vor Biopharma Inc. | CFO | Sell | 50.0 | -834 | -0.54% | ✗ | $3.5K |
| Mar 1, 2023 | Mar 2, 2023 | Vor Biopharma Inc. | CFO | Sell | 46.3 | -6,310 | -3.92% | ✗ | $34.8K |